key: cord-0977314-wz0p5055
authors: Szekely, Yishay; Lichter, Yael; Sadon, Sapir; Lupu, Lior; Taieb, Philippe; Banai, Ariel; Sapir, Orly; Granot, Yoav; Hochstadt, Aviram; Friedman, Shirley; Laufer-Perl, Michal; Banai, Shmuel; Topilsky, Yan
title: Cardiorespiratory Abnormalities in Patients Recovering from COVID-19
date: 2021-09-08
journal: J Am Soc Echocardiogr
DOI: 10.1016/j.echo.2021.08.022
sha: e030be2f327dc3b71396000d397cf2e2201623e1
doc_id: 977314
cord_uid: wz0p5055

Background Large number of patients around the world are recovering from COVID-19; many of them report persistence of symptoms. Objectives We sought to test pulmonary, cardiovascular and peripheral responses to exercise in patients recovering from COVID-19. Methods We prospectively evaluated patients who recovered from COVID-19 using a combined anatomic/functional assessment. All patients underwent clinical examination, laboratory tests, and a combined stress echocardiography and cardiopulmonary exercise test. We measured left ventricular volumes, ejection fraction, stroke volume, heart rate, E/e' ratio, right ventricular function, VO2, lung volumes, Ventilatory efficiency, O2 saturation and muscle O2 extraction in all effort stages and compared them to historical controls. Results A total of 71 patients were assessed 90.6±26 days after onset of COVID-19 symptoms. Only 23 (33%) were asymptomatic. The most common symptoms were fatigue (34%), muscle weakness/pain (27%) and dyspnea (22%). VO2 was lower among post-COVID-19 patients compared to controls (p=0.03, group by time interaction p=0.007). Reduction in peak VO2 was due to a combination of chronotropic incompetence (75% of post-COVID-19 patients vs. 8% of controls, p<0.0001) and insufficient increase in stroke volume during exercise (p=0.0007, group by time interaction p=0.03). Stroke volume limitation was mostly explained by diminished increase in left ventricular end-diastolic volume (p=0.1, group by time interaction p=0.03) and insufficient increase in ejection fraction (p=0.01, group by time interaction p=0.01). Post-COVID-19 patients had higher peripheral O2 extraction (p=0.004) and did not have significantly different respiratory and gas exchange parameters compared to controls. Conclusions Patients recovering from COVID-19 have symptoms associated with objective reduction in peak VO2. The mechanism of this reduction is complex and mainly involves a combination of attenuated heart rate and stroke volume reserve.

The majority of publications concerning cardiovascular manifestations of COVID-19 deal with the acute infection. [1] [2] [3] In contrast, less is known about the long-term cardiovascular consequences of COVID-19. Researchers describe a high incidence of fatigue, dyspnea, muscle pain, chest pain and neuropsychiatric symptoms among patients recovered from COVID-19 infection. [4] [5] [6] Other researchers in Germany, China, the U.S. and the U.K. described the extent of cardiac injury in recovered patients. [7] [8] [9] [10] [11] These studies, however, used only cardiac imaging performed at rest. [7] [8] [9] [10] [11] Impaired exercise capacity in patients recovering from COVID-19 infection may be multifactorial.

Apart from ventilatory or gas exchange abnormalities secondary to residual pulmonary disease, attenuated increase in stroke volume could be the result of left ventricular (LV) dysfunction due to myocarditis or cytokine dysregulation, [12] [13] [14] right ventricular (RV) dysfunction induced by pulmonary hypertension, and diastolic dysfunction. 1, 15 Other possible causes include chronotropic incompetence and reduced peripheral oxygen extraction due to direct viral damage or deconditioning secondary to muscle disuse. None of these previous studies included any form of objective functional assessment.

Given the large number of patients recuperating from COVID-19, functional studies to help delineate the cause of post-COVID-19 symptoms are needed.

Cardiopulmonary exercise test (CPET) is the gold standard for assessment of integrative exercise responses involving the pulmonary, cardiovascular, and skeletal muscle systems. 16, 17 CPET objectively categorizes physical effort during pre-defined activity levels (rest, anaerobic-threshold and peak exercise), providing factual assessment of pulmonary and cardiac function, as well as estimations of peripheral vascular resistance during all exercise stages. Furthermore, since COVID-19 infection severe enough to require medical attention manifests with lung injury 18 and often has cardiac complications, 1 we also performed echocardiography at rest. Our CPET protocol also included echocardiography performed during anaerobic-threshold and maximal exercise. 19 , 20 We previously showed that these combined exams allow accurate discrimination of different causes of effort intolerance, by recognizing ventilatory limitation, abnormal gas exchange, limited stroke J o u r n a l P r e -p r o o f volume reserve, chronotropic incompetence and/or reduced peripheral muscular oxygen extraction. 19, 20 Two previous small studies of patients recovered from COVID-19 who underwent CPET showed mostly ventilatory and presumed muscular limitations to exercise. 21, 22 A study of pulmonary function and a 6-minute-walking-distance in patients recovering from acute showed worse diffusion capacity, lung volumes and a shorter walking distance in patients recovering from a severe acute disease, compared to a mild disease. 23 We aimed to test whether pulmonary, cardiovascular and peripheral responses to exercise in patients recovered from COVID-19 are abnormal and correlate with residual symptoms.

Study protocol. We prospectively evaluated individuals recovering from COVID-19 in a dedicated outpatient clinic. All patients had a well-established diagnosis of COVID-19 infection, survived the acute event and met the World Health Organization criteria for discontinuation of quarantine.

Inclusion criteria was all COVID-19 patients who were evaluated in the emergency room in the Tel-Aviv Medical Center, including those requiring hospitalization and those subsequently treated as outpatients, ranging from mild to critical acute disease according to the National Institutes of Health definitions (Mild-signs and symptoms not including shortness of breath or dyspnea on exertion, without abnormal imaging; Moderate-evidence of lower respiratory disease during clinical assessment or imaging, with SpO2 ≥94% on room air; Severe-SpO2 <94% on room air, a respiratory rate >30 breaths/min, PaO2/FiO2 <300 mmHg, or lung infiltrates >50%; Critical-acute respiratory distress syndrome, septic shock and multi-organ involvement). The only exclusion criteria were inability to provide informed consent or refusal to participate in the study. All patients underwent a comprehensive medical assessment with detailed history, physical examination and blood tests. We specifically inquire about symptoms related to effort intolerance. Dyspnea was defined as the subjective experience of breathing discomfort comprised of qualitatively distinct sensations varying in intensity. We also performed a comprehensive cardiopulmonary evaluation that included: 1) rest J o u r n a l P r e -p r o o f echocardiography; 2) lung spirometry and 3) combined CPET and exercise-echocardiography to objectively discriminate between the mechanisms responsible for different symptoms. The study was approved by the institutional review board (IRB number 0574-16-TLV). All patients provided informed consent. Patients recovered from COVID-19 were compared to 35 control patients. The controls were selected using a frequency-matching approach from a pool of 76 patients that performed combined CPET and stress echocardiography, using the same protocol, demonstrating normal peak oxygen consumption (VO2) at our institution. The predefined baseline matching parameters were age (within 5 years), height (within 10 cm), weight (within 10 kg), exact gender, and prevalence of ischemic heart disease, diabetes and hypertension. The selection process achieved groups with comparable determinants of peak VO2 and balanced comorbidities. The groups are different in size as there were no set couples of matched patients. Subanalyses included comparing patients recovered from COVID-19 infection who had persistent symptoms (fatigue, dyspnea or muscle weakness/pain) with patients who were free of these symptoms and comparing patients recovered from COVID-19 infection according to their acute disease severity. The CPET and echocardiographic results of patients recovered from COVID-19 were also compared to well-characterized reference values. 16, 17, 24 Rest echocardiography. Echocardiography was performed, as recommended, 24-26 by cardiologists with expertise in echocardiographic acquisition and interpretation and using the same equipment for all patients (CX 50, Philips Medical Systems).

A symptom-limited graded-ramp bicycle exercise-test was performed in the semisupine position on a tilting dedicated microprocessor-controlled eddy current brake stress echo cycle ergometer (Ergoselect 1000 L, CareFusion) (Supplementary methods appendix). Forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) were measured before exercise.

Maximal voluntary ventilation was calculated by multiplying the FEV1 by 35. 17 We estimated the expected peak VO2 based on patient's age, height and weight, with equation pertaining to bicycle testing. 16, 17, 27 Breath-by-breath minute ventilation (VE), carbon dioxide production (VCO2), their ratio that represents ventilatory efficiency (VE/VCO2) and VO2 were measured using a Medical J o u r n a l P r e -p r o o f Graphics metabolic cart (ZAN, nSpire Health). The O2-pulse was calculated as VO2/heart rate. 28 Anaerobic-threshold was determined manually using the modified V-slope method. 17 Arterial blood oxygen-saturation was measured using noninvasive pulse oximetry. The intensity of dyspnea or fatigue was assessed using the modified Borg scale. The exercise-effort quality was assessed by respiratory-exchange-ratio (RER) at peak exercise. A 12-lead ECG was monitored continuously, heart rate and blood pressure were measured at rest and every minute during exercise. Heart rate (HR) reserve was calculated as the change in HR from rest to peak exercise, divided by the difference between the age-predicted maximal HR and the resting HR. Chronotropic incompetence was defined as failure to achieve ≥80% of the HR reserve during exercise. 29 In patients treated with β-blockers, chronotropic incompetence was defined as failure to achieve >62% of the HR reserve. 30 Stress Echocardiography testing. Echocardiography images were obtained concurrently with breath-by-breath gas exchange measurements at rest, immediately after reaching a stable RER ≥1.00 (Anaerobic-threshold), and at peak effort by a single cardiologist (YS). 19, 20 Data collected at each time period included left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), LV ejection fraction (LVEF), stroke volume (SV), Peak E-wave velocity, e′ in the septal and lateral mitral annulus, tricuspid annular plane systolic excursion (TAPSE) and right ventricular (RV) S'. LV diameters, volumes and LVEF were measured as recommended, by 2D echocardiography. 25 Forward SV was calculated from LV outflow tract Doppler with subsequent calculation of cardiac output and index.

A-VO2 difference, that represents O2 extraction by the muscles, was calculated by using the Fick equation at each activity level. 31, 32 Since there are no reference values for LVEDV, LVESV and A-VO2 difference in response to exercise, we selected the cutoffs for these parameters based on our previous work and corroborated the cutoffs on our control cohort. 33 Cutoff values for RV stress echocardiography parameters were derived from the recommendations of the European Association of Cardiovascular Imaging. 34 J o u r n a l P r e -p r o o f All tests were analyzed by an experienced physician who was unaware of participant group or symptomatology (YT). (Supplementary methods appendix).

were determined by a second independent blinded observer who measured these variables in 15 randomly selected patients. Intra-observer variability was determined by having the observer who measured the data in all patients re-measure the echo variables in 15 patients one week apart. Interobserver and intra-observer variability were assessed using the intraclass correlation coefficient (ICC) and the within-subject coefficient of variation (calculated as the ratio of the standard deviation of the measurement difference to the mean value of all measurements). An ICC > 0.85 has been used as a measure of good variability and positive reproducibility for the measurements.

Descriptive results are expressed as mean±SD for continuous variables and as percentages for categorical variables. The distribution of continuous variables was tested to ensure that normality assumptions were fulfilled. Group comparisons used ANOVA, Wilcoxon test, Fisher's exact test or Chi-square test, as appropriate. To compare sample means to known reference values a one-sample t-test was used. For the comparison to the control group, or between subgroups, and to avoid bias incurred by multiple comparisons, we used the repeated-measures linear-model analysis to define the within-group effect for each parameter over time, the between group differences over time, and the group by time interactions. To analyze independent determinants of exercise tolerance, the primary endpoint was peak VO2. Stepwise multivariate linear-regression models (with the peak VO2 as the dependent variable and the different clinical, CPET, echo or combined CPET and exercise-echocardiography variables as independent variables) were performed. To correct for possible overfitting of the model considering that there were only 71 subjects, we grouped the variables into clinical, laboratory, LV, RV, respiratory, and peripheral parameters. The first step was to select for each group all the variables with P<0.05 in a univariable analysis. In the second step, to detect multi-collinearity, we used correlation factor analyses to determine if any pairs of predictor variables were highly correlated (correlation coefficients over J o u r n a l P r e -p r o o f 0.7) and therefore likely to result in multi-collinearity. In the third step, in each sub-group the variable with the lowest p value was chosen to be included in the analysis. Because of their known association with peak VO2, we forced age and gender into all analyses. The final parameters included age, gender, Troponin, heart rate, stroke volume, TAPSE and A-VO2 difference. All computations were performed using JMP statistical software for Windows (Version 9.0; SAS Institute).

We identified 165 consecutive adult patients who presented to the Tel-Aviv Medical Center (between (67%) had one or more of the following symptoms: fatigue (34%), muscle weakness or pain (27%), dyspnea (22%), chest pain (18%), anxiety (17%), and anosmia (12%). The mean time after acute illness did not differ between the patients with or without symptoms (88.8±20 vs. 88.6±24 days, p=0.98). Symptomatic status was independent of time after acute illness (HR 1.00, CI [0.96-1.04];

p=0.98). Baseline characteristics of the study cohort are presented in Table 1 . Baseline characteristics of patients who did not undergo the post-COVID-19 evaluation are shown in supplementary Table 1 .

These patients were older and had higher rates of diabetes and heart failure.

The 35 historical control patients were matched for main clinical characteristics and comorbidities (age, gender, weight, height, hypertension, diabetes). Baseline characteristics, echocardiographic and CPET parameters of the study cohort compared to controls are shown in Table 1 .

Combined cardiopulmonary exercise test and stress echocardiography. The results of the CPET and stress echocardiography during different stages of exertion of the study cohort compared to controls are shown in Table 1 , Table 2 Table 3 ).

Patients who reported on-going symptoms were compared to asymptomatic patients (Table 3) . Patients who were symptomatic had smaller left ventricles and higher LVEF. There was no difference in peak VO2, heart rate, stroke volume, cardiac output, E/e' ratio, tidal volume, VE/VCO2 ratio or A-VO2 difference. Supplementary Figures 1-3 Table 4 .

Inter-observer and intra-observer variability. Comparison of inter-and intra-observer LV enddiastolic and end-systolic volumes showed good agreement between measurements (Supplementary Table 5 ).

This is the first study evaluating patients recovered from COVID-19 infection with a combined stress echocardiography and cardiopulmonary exercise test. Assessing patients in separate stages of effort, J o u r n a l P r e -p r o o f including anaerobic-threshold, is more relevant to everyday activity than peak exercise alone. Our study represents an attempt to objectively explain the functional impairment reported by many patients recovering from COVID-19. Our major findings are: 1) two thirds of the patients report at least one residual symptom, similar to previous publications. 4-6 2) Abnormally low peak VO2 is common among patients recovering from COVID-19; 3) the mechanism of the reduction is a combination of chronotropic incompetence and attenuated stroke volume reserve and is different according to specific symptoms; 4) Severe gas exchange abnormalities or very limited breathing reserve are rather rare causes of effort intolerance; 5) chronotropic incompetence, limited stroke volume reserve, limited RV systolic reserve and peripheral factors (low peak A-VO2 difference) each contribute independently to the reduced exercise capacity in patients recovering from COVID-19.

In patients recovering from COVID-19, peak-exercise heart rate was reduced and contributed to their limited exercise capacity. Interestingly, chronotropic incompetence was equally present in patients recovering from mild/moderate or severe/critical acute disease.

Furthermore, chronotropic incompetence was specifically more common among patients complaining of dyspnea and/or fatigue compared to patients free of these symptoms and was a strong independent predictor of peak VO2. Moreover, we found that chronotropic incompetence was not the consequence of reduced motivation during CPET (as demonstrated by RER). Based on the available data, it is not possible to determine why patients recovering from COVID-19 infection have chronotropic incompetence, thus, further research is necessary in this area.

Normally, stroke volume increases during exercise until the anaerobic-threshold, secondary to increase in LVEDV and contractility, both resulting from heightened adrenergic tone. Then, the stroke volume plateaus due to increased tachycardia and shortened filling time of the LV. 20 Insufficient increase in stroke volume during initial stages of stress seen in post-COVID-19 patients compared to controls, may be the result of either insufficient increase in LVEDV or to a blunted increase in contractility. While we cannot determine the exact mechanism responsible for this limitation, several explanations exist: 1) Reduced LV contractile reserve (Online J o u r n a l P r e -p r o o f Video 1). Acute COVID-19 can induce endothelialitis 35 that may cause microvascular dysfunction resulting in LV contractile abnormalities. Microvascular dysfunction usually manifests with reduced VO2 max, preserved anaerobic threshold, ST segment abnormalities, low peak O2 pulse with failure of VO2 and O2 pulse to increase appropriately at the last phase of exercise, associated with decreasing stroke volume and increasing A-VO2 difference. 36 2) Diastolic dysfunction with poor LV compliance and increased LV filling pressure. In our cohort, only one patient had an increase in E/e' above 14 suggestive of increased LV filling pressure; 3) A reduced RV systolic reserve resulting in poor LV filling (Online Video 2). This was the case in 8 patients in our cohort. Right ventricular dysfunction is well-described among hospitalized patients with acute COVID-19 1,37 and may persist into recovery; 4) Severe dehydration or bleeding. None of the studied patients had clinical or laboratory parameters to suggest either of them; 5) Insufficient recruitment of blood from the splanchnic vascular compartment, that has been historically termed "vaso-regulatory asthenia" 33,34,38 (Online Video 3).

We cannot exclude this etiology in our cohort. Autonomic dysregulation was not directly assessed in our study but interestingly it can result in both chronotropic incompetence and abnormal blood flow distribution. It has been described in post-COVID-19 patients and may explain these two main abnormalities. [39] [40] [41] Peripheral factors. Peak A-VO2 difference is an independent predictor of reduced exercise capacity.

Surprisingly, patients recovering from COVID-19 infection had higher peak A-VO2 difference than controls. Since patients recovering from COVID-19 had reduced peak VO2 compared to controls, the increase in peak A-VO2 difference suggests that patients recovering from COVID-19 attempt to compensate for a reduced cardiac output by increasing peripheral muscle oxygen extraction resulting in increased peak A-VO2 difference, and that the reduced peak VO2 is not merely the result of longlasting deconditioning. This contrasts the conclusions of a prior study of 10 post-COVID-19 patients with persistent dyspnea who underwent CPET. 22 In that study, 8/10 patients were found to have abnormally low peak VO2 (<85% from predicted), but only one had a cardiac limitation and two had ventilatory limitations. The authors concluded that metabolic limitation and muscular deficiency are J o u r n a l P r e -p r o o f the likely etiology in the rest of the patients. We show that a cardiac limitation is more likely than a peripheral muscular limitation.

illness ranging from mild upper respiratory disease to severe pneumonia. Surprisingly, we found that during the recovery phase, baseline respiratory parameters were normal in the majority of patients, and that limited breathing reserve was the limiting factor for effort in only three (4%) patients. Severe abnormal gas exchange was also rare. Nevertheless, as opposed to hemodynamic parameters, ventilatory and gas exchange abnormalities were more common in patients recovering from severe/critical compared to mild/moderate acute disease. During exercise, elevated breathing rate, increased VE/VCO2, and low oxygen saturation were notable only in patients recovering from severe/critical acute infection, probably reflecting residual pulmonary damage. Similar findings were found in a study of 28 post-COVID-19 patients who underwent CPET, in which 8 patients were found to have elevated VE/VCO2, reflecting an exercise ventilatory inefficiency and related to lower heart rate recovery. 21 In a study of 57 post-COVID-19 patients who underwent pulmonary function and 6minute-walk tests, the patients were found to have impaired diffusion capacity and lower lung volumes. Those with history of severe infection, compared to those with non-severe infection, had a higher incidence of these abnormalities, as well as shorter 6-minute-walk-test. 23 Subgroup analysis based on symptoms. We show how patients with specific symptoms compared to patients free from that symptom. Patients with dyspnea were found to have various cardiac and respiratory abnormalities in response to exercise, while patients presenting with fatigue presented mostly with attenuated HR response. Patients suffering from muscle weakness or pain did not have significantly different CPET parameters compared to those who did not. As a whole, symptomatic patients did not have significant differences in peak VO2 and other CPET parameters compared to asymptomatic patients. This could be explained by the fact that many survivors of COVID-19 continue to report different psychological and emotional difficulties 42, 43 that can also present with physical symptoms, without an objective limitation.

J o u r n a l P r e -p r o o f Study limitations. The present analysis was performed in a single point in time around 3 months following COVID-19 acute infection, and it is unknown whether the abnormalities identified will translate into long-term abnormalities. We report that peak heart rate is blunted in patients recovered from COVID-19 but we cannot exclude the possibility that the continued effects of blocker, or mild ventilatory limitations may have influenced the blunted heart rate response.

Nevertheless, the results were unchanged when adjustments were performed for long-term blocker use, and a very low breathing reserve was a very rare cause of effort limitation in our cohort. Our imaging protocol was performed in the semi-supine position, which generates somewhat different hemodynamic response than the more commonly-used treadmill exercise. SV and cardiac output measurements may have been underestimated or overestimated due to the technical challenge of acquiring echocardiography images during exercise. However, this technique has been used successfully and validated against radionuclide angiography and Fick stroke volume and reported excellent day-to-day reproducibility and intra-observer and inter-observer variability. 31 A-VO2 difference was not independently measured, but was calculated using the Fick equation as VO2/CO. 31, 32 The number of patients who had severe or critical acute disease was small and underpowered to detect clinically significant differences in peak VO2 compared to patients with mild or moderate acute disease. It is possible that a bigger cohort of such patients would yield a stronger association between acute disease severity and different exercise abnormalities. Selection bias is inherent to this study. First, this study included only patients that required emergency room evaluation during their acute COVID-19. Second, 20% of patients died during their acute illness.

Lastly, among patients who were discharged alive, considerable number of patients could not perform CPET due to immobilization or did not agree to participate. We present a limited-sized cohort. As matching our cohort to historical data may introduce potential unknown confounders, the differences in CPET and stress echocardiography parameters between patients recovering from COVID-19 infection and the control group should be interpreted cautiously. J o u r n a l P r e -p r o o f

Spectrum of Cardiac Manifestations in COVID-19. Circulation

Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications

COVID-19 is, in the end, an endothelial disease

Persistent Symptoms in Patients After Acute COVID-19

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection

Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging

Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance

Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation

Echocardiographic Features of COVID-19 Illness and Association with Cardiac Biomarkers

Echocardiographic Findings in Patients with COVID-19 with Significant Myocardial Injury

Indications for and Findings on Transthoracic Echocardiography in COVID-19

Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association

EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations

Lung ultrasound predicts clinical course and outcomes in COVID-19 patients

Mechanisms of Effort Intolerance in Patients With Rheumatic Mitral Stenosis: Combined Echocardiography and Cardiopulmonary Stress Protocol

Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol

Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19. Diagnostics (Basel)

Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19

Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase

Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Normal cardiopulmonary responses during incremental exercise in 20-to 70-yr-old men

Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications

Chronotropic incompetence: causes, consequences, and management. Circulation

Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol)

Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction

Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, singleblind trial

Discriminating Circulatory Problems From Deconditioning: Echocardiographic and Cardiopulmonary Exercise Test Analysis

The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications

The Predictive Role of Combined Cardiac and Lung Ultrasound in Coronavirus Disease

Vasoregulatory asthenia

Autonomic dysfunction following COVID-19 infection: an early experience

Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience

Autonomic dysfunction in "long COVID": rationale, physiology and management strategies

Post-acute COVID-19 syndrome

Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge